Combigan FDA Approval History
FDA Approved: Yes (First approved October 30, 2007)
Brand name: Combigan
Generic name: brimonidine tartrate and timolol maleate
Dosage form: Ophthalmic Solution
Company: AbbVie Inc.
Treatment for: Intraocular Hypertension, Glaucoma
Combigan (brimonidine tartrate and timolol maleate) is an alpha adrenergic receptor agonist and beta adrenergic receptor inhibitor combination ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP.
Development timeline for Combigan
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.